Commentary|Podcasts|May 29, 2024
AI in Clinical Trials: A Long, But Promising Road Ahead
Author(s)Miranda Schmalfuhs
Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Stephen Pyke, chief clinical data and digital officer, Parexel discusses:
- A broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it
- How AI can be used in clinical trials to streamline operational processes
- The importance of collaboration and data sharing in advancing the use of technology, and more
- The importance of considering the experience of patients when integrating artificial intelligence as well as some of the benefits they will see from it
- Human oversight when using artificial intelligence to aid in decision making
Related Content
Trending on Applied Clinical Trials Online
1
You've Been Spending Recruitment Money at the Wrong End of the Funnel
2
ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps
3
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
4
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
5